Headline News:
Data Provide Evidence that Genous Could Be Treatment for Patients Not Suitable for Long Term DAPT
March 12th, 2010
Wayne Johnson has over 20 years of medical device experience, primarily in the areas of general management, operations, and product development. Prior to OrbusNeich, he was president and CEO of Sutura, Inc., a development stage company based in Fountain Valley, California focused on commercializing suture-mediated wound closure products. Preceding Sutura, he was president and CEO of Prostec, LLC (a division of Syntheon, LLC), focused on devices for prostate brachytherapy. Prior to Prostec, he was employed by Cordis for 18 years, during which time he held various roles of increasing responsibility including vice president and general manager of Cordis' largest facility. He was also a member of the Cordis operating board as vice president of worldwide operations. He holds a BS in biology and both an MBA and an MS in management from Rensselaer Polytechnic Institute.